Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Male-specific lethal 3 homolog is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
MSL3 |
Gene ID: |
10943 |
Uniprot ID: |
MS3L1_HUMAN |
Specificity: |
This antibody detects endogenous levels of MSL3 at Human, Mouse |
Immunogen: |
Synthesized peptide derived from human MSL3 |
Function | Has a role in chromatin remodeling and transcriptional regulation. Has a role in X inactivation. Component of the MSL complex which is responsible for the majority of histone H4 acetylation at 'Lys-16' which is implicated in the formation of higher-order chromatin structure. Specifically recognizes histone H4 monomethylated at 'Lys-20' (H4K20Me1) in a DNA-dependent manner and is proposed to be involved in chromosomal targeting of the MSL complex. |
Protein Name | Male-Specific Lethal 3 HomologMale-Specific Lethal-3 Homolog 1Male-Specific Lethal-3 Protein-Like 1Msl3-Like 1 |
Database Links | Reactome: R-HSA-3214847 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Male-Specific Lethal 3 Homolog antibodyAnti-Male-Specific Lethal-3 Homolog 1 antibodyAnti-Male-Specific Lethal-3 Protein-Like 1 antibodyAnti-Msl3-Like 1 antibodyAnti-MSL3 antibodyAnti-MSL3L1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance